Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/20/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/20/20 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 10/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
81 |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/01/20 | 8-K | Current report filing |
|
4 |
